(POET) POET Technologies - Ratings and Ratios
Interposer, Photonic Circuits, Optical Engines, Packaging
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 144% |
| Value at Risk 5%th | 179% |
| Relative Tail Risk | -24.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 5.22 |
| CAGR/Max DD | 0.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.653 |
| Beta | 1.952 |
| Beta Downside | 1.288 |
| Drawdowns 3y | |
|---|---|
| Max DD | 86.30% |
| Mean DD | 40.90% |
| Median DD | 36.80% |
Description: POET POET Technologies October 27, 2025
POET Technologies Inc. (NASDAQ: POET) designs, develops, manufactures, and sells semiconductor-based photonic integrated packaging (PIP) solutions, leveraging its proprietary POET Optical Interposer to co-integrate electronic and photonic components on a single wafer-level chip.
The company’s product suite includes the Optical Interposer platform, photonic integrated circuits (PICs), and optical engines that target high-growth markets such as data-center interconnects, 5G front-haul (PON/GPON), edge computing, LIDAR, optical coherence tomography (OCT) for medical devices, and virtual-reality optics.
Key recent metrics (FY 2023): revenue of $112 million, up 28 % year-over-year; R&D expense of $22 million (≈ 20 % of revenue) reflecting aggressive technology investment; and a cash-and-cash-equivalents balance of $45 million, providing runway for scaling production capacity.
Sector-level drivers that materially affect POET’s outlook include the accelerating demand for bandwidth in hyperscale data centers (projected CAGR ≈ 12 % through 2028), the global rollout of 5G networks (expected to add > 1 billion new connected devices by 2030), and the rapid commercialization of LIDAR and OCT in autonomous-vehicle and medical-imaging applications, which together create a multi-trillion-dollar addressable market for photonic integration.
For a deeper, data-rich assessment of POET’s valuation and risk profile, you may find the analyst tools on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-50.6m TTM) > 0 and > 6% of Revenue (6% = 45.8k TTM) |
| FCFTA -0.33 (>2.0%) and ΔFCFTA 8.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6939 % (prev 19.7k%; Δ -12.7kpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.26 (>3.0%) and CFO -28.2m > Net Income -50.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (89.8m) change vs 12m ago 37.82% (target <= -2.0% for YES) |
| Gross Margin -77.71% (prev -1181 %; Δ 1104 pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.96% (prev 0.24%; Δ 0.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -158.8 (EBITDA TTM -17.8m / Interest Expense TTM 127.2k) >= 6 (WARN >= 3) |
Altman Z'' -7.11
| (A) 0.49 = (Total Current Assets 93.7m - Total Current Liabilities 40.8m) / Total Assets 107.8m |
| (B) -2.70 = Retained Earnings (Balance) -291.3m / Total Assets 107.8m |
| warn (B) unusual magnitude: -2.70 — check mapping/units |
| (C) -0.26 = EBIT TTM -20.2m / Avg Total Assets 79.2m |
| (D) 0.18 = Book Value of Equity 7.46m / Total Liabilities 41.4m |
| Total Rating: -7.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.56
| 1. Piotroski 0.50pt |
| 2. FCF Yield -4.98% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.11 |
| 5. Debt/Ebitda 0.35 |
| 6. ROIC - WACC (= -45.83)% |
| 7. RoE -119.7% |
| 8. Rev. Trend 25.25% |
| 9. EPS Trend -24.89% |
What is the price of POET shares?
Over the past week, the price has changed by +7.44%, over one month by +28.71%, over three months by +24.05% and over the past year by +49.43%.
Is POET a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the POET price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.6 | 1.5% |
| Analysts Target Price | 6.6 | 1.5% |
| ValueRay Target Price | 6 | -7.1% |
POET Fundamental Data Overview December 05, 2025
P/S = 1038.3385
P/B = 9.282
Beta = 0.451
Revenue TTM = 762.7k USD
EBIT TTM = -20.2m USD
EBITDA TTM = -17.8m USD
Long Term Debt = 784.1k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.65m USD (from shortTermDebt, last quarter)
Debt = 7.28m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -6.23m USD (from netDebt column, last quarter)
Enterprise Value = 706.5m USD (791.9m + Debt 7.28m - CCE 92.7m)
Interest Coverage Ratio = -158.8 (Ebit TTM -20.2m / Interest Expense TTM 127.2k)
FCF Yield = -4.98% (FCF TTM -35.2m / Enterprise Value 706.5m)
FCF Margin = -4615 % (FCF TTM -35.2m / Revenue TTM 762.7k)
Net Margin = -6628 % (Net Income TTM -50.6m / Revenue TTM 762.7k)
Gross Margin = -77.71% ((Revenue TTM 762.7k - Cost of Revenue TTM 1.36m) / Revenue TTM)
Gross Margin QoQ = -199.1% (prev 100.0%)
Tobins Q-Ratio = 6.55 (Enterprise Value 706.5m / Total Assets 107.8m)
Interest Expense / Debt = 0.43% (Interest Expense 31.4k / Debt 7.28m)
Taxrate = 21.0% (US default 21%)
NOPAT = -16.0m (EBIT -20.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.30 (Total Current Assets 93.7m / Total Current Liabilities 40.8m)
Debt / Equity = 0.11 (Debt 7.28m / totalStockholderEquity, last quarter 66.4m)
Debt / EBITDA = 0.35 (negative EBITDA) (Net Debt -6.23m / EBITDA -17.8m)
Debt / FCF = 0.18 (negative FCF - burning cash) (Net Debt -6.23m / FCF TTM -35.2m)
Total Stockholder Equity = 42.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -46.88% (Net Income -50.6m / Total Assets 107.8m)
RoE = -119.7% (Net Income TTM -50.6m / Total Stockholder Equity 42.2m)
RoCE = -46.95% (EBIT -20.2m / Capital Employed (Equity 42.2m + L.T.Debt 784.1k))
RoIC = -32.74% (negative operating profit) (NOPAT -16.0m / Invested Capital 48.7m)
WACC = 13.09% (E(791.9m)/V(799.2m) * Re(13.21%) + D(7.28m)/V(799.2m) * Rd(0.43%) * (1-Tc(0.21)))
Discount Rate = 13.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 46.10%
Fair Price DCF = unknown (Cash Flow -35.2m)
EPS Correlation: -24.89 | EPS CAGR: 1.87% | SUE: -0.09 | # QB: 0
Revenue Correlation: 25.25 | Revenue CAGR: 127.5% | SUE: -1.89 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.19 | Chg30d=+0.070 | Revisions Net=-1 | Growth EPS=+34.5% | Growth Revenue=+710.6%
Additional Sources for POET Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle